Balancing Personalization & Scalability in TCR-T Cell Therapies to Scale the Modality
- Examining drivers of efficiency in scalable personalized TCR-T asset development
- Synthesizing discovery with manufacturing to drive scalability of product development
- Designing clinical programs for near-term outcomes and pathways to approvals